FindTrial
Sign In

Evaluation and prognostic assessment of peripheral blood apelin levels in patients with acute ST-elevation myocardial infarction

Evaluation and prognostic assessment of peripheral blood apelin levels in patients with acute ST-elevation myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ODT-13004019
Enrollment
Unknown
Registered
2013-12-20
Start date
2012-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ST-elevation myocardial infarction

Interventions

pPCI:primary PCI
ePCI:elective PCI
SA:elective PCI
Control:none

Sponsors

Dept. Cardiology, Huizhou Municipal Central Hospital, Guangdong, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 93 consecutive STEMI patients who underwent primary PCI. Patients who underwent elective PCI, including 30 STEMI patients and 30 patients with stable angina. Ten healthy people were selected as controls.

Exclusion criteria

Exclusion criteria: History of myocardial infarction,severe valvular heart disease,congenital heart disease,chronic cardiac failure,Severe damage to liver and kidney function,and serious infection.

Design outcomes

Primary

MeasureTime frame
apelin;—

Secondary

MeasureTime frame
NT-proBNP;—

Countries

China

Contacts

Public ContactShen Jian

Huizhou Municipal Central Hospital, Guangdong, China

alberten@163.com+86 18819642678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026